EVOGENE ANNOUNCES ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) AS THE TARGET INDICATION FOR ITS INTERNAL AI-DRIVEN DRUG DISCOVERY PROGRAM

Reuters · 2d ago

Please log in to view news